Suchergebnisse

1728 Treffer:
Sphincter lesions after radical prostatectomy – evaluation and classification.
Gerullis H, Quast S, Eimer C, Bagner JW, Otto T.
Nephro-cutaneous bypass in ureteral obstruction.
Gerullis H, Ecke TH, Schwartmann K, Heuck CJ, Eimer C, Bagner J, Kocheril S, Otto T.
Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma.
Gerullis H, Bergmann L, Maute L, Ecke T, Eimer C, Bagner J, Otto T.
Experiences and practical conclusions concerning Temsirolimus use and Adverse Event Management in advanced Renal Cell Carcinoma within a Compassionate Use Program in Germany.
Gerullis H, Bergmann L, Maute L, Eimer C, Otto T.
Laparoscopic Cystectomy with Extracorporeal-Assisted Urinary Diversion: Experience with 34 Patients.
Gerullis H, Kümmel C, Popken G.
Repair of a vesico-vaginal fistula with amniotic membrane – Step 1 of the IDEAL recommendations of surgical innovation.
Barski D, Gerullis H, Ecke Th, Varga G, Boros M, Pintelon I, Timmermans JP, Winter A, Bagner JW, Otto Th.
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.
Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Barnes HF, Matullo G, Golka K, Gago-Dominguez M, Taylor J, Fletcher T, Siddiq…
mTOR-inhibition in metastatic renal cell carcinoma- focus on temsirolimus: a review.
Gerullis H, Ecke TH, Eimer C, Heuck CJ, Otto T.
Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy.
Gerullis H.
Targeted agents in second line bladder cancer therapy .
Gerullis H, Otto T, Ecke TH.
Suchergebnisse 1161 bis 1170 von 1728